An overview of the hypolipidemic effect of Genus Berberis
Sandoval, Héctor
Journal
Tropical Journal of Pharmaceutical Research
ISSN
1596-9827
1596-5996
Open Access
gold
Volume
23
Start page
1939
End page
1947
Dyslipidemia is a chronic disease characterized by elevated blood lipid levels treatable with statins. However, long-term statin use may have adverse effects, such as liver damage and memory loss. Nevertheless, plants and their active compounds effectively and safely improve lipid profiles. This review aims to update information on the genus Berberis as a hypolipidemic agent, assess the effects of these extracts on organisms and provide evidence supporting the use of these natural products in pharmaceutical drugs. Berberis species with therapeutic potential include B. vulgaris, B. integerrima, B. aristata, B. lycium, B. orthobotrys, and B. calliobotrys, which have shown promising results in reducing lipid levels in humans and other animals. In addition, combining berberine with nutraceuticals may improve its intestinal absorption, enhancing its lipid-lowering effect. Herbal medicine studies suggest that Berberis has a high potential for the management of hyperlipidemia.
Name
2024_23_11_19.pdf
Size
214.03 KB
Format
Adobe PDF
Checksum
(MD5):b246ff9fcd0d858ce34273ea3dcb869e
Attribution 4.0 International